论文部分内容阅读
1979年,我们曾试用正常核糖核酸(RNA)治疗慢性肝炎和肝硬化取得一定的疗效,并发现其对患者血清蛋白的疗效尤为显著。由动物实验尚证明,RNA有增进正常小鼠肝细胞合成蛋白质的作用。在此基础上,我们重点观察了RNA对慢性活动性肝炎(CAH)血清蛋白的疗效。自1979至1985年间,总共以RNA治疗CAH82例,并以辅酶Q_(10)治疗CAH20例进行对照观察,进一步证明RNA有明显改善CAH患者血清蛋白的疗效。现报告如下:对象及方法一、治疗对象:选择CAH而有血清蛋白电泳异常的病例为治疗对象。CAH的诊断均参照1978年第一届全国病毒性肝炎学术会议
In 1979, we experimented with normal RNA for the treatment of chronic hepatitis and cirrhosis, and found that the effect on serum albumin was particularly significant. Animal experiments have also proved that RNA can enhance the normal mouse hepatocyte protein synthesis. On this basis, we have focused on the RNA effects on serum proteins of chronic active hepatitis (CAH). From 1979 to 1985, a total of 82 cases of CAH treatment of CAH, and coenzyme Q_ (10) treatment of 20 cases of CAH control study, further evidence that RNA can significantly improve the efficacy of serum protein in patients with CAH. Are reported as follows: Subjects and methods First, the treatment of patients: the choice of CAH and serum protein electrophoresis abnormalities in the treatment of patients. The diagnosis of CAH refer to the first national conference on viral hepatitis in 1978